News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neogenix Oncology, Inc. Will Present Data on a New Stool Biomarker Test for the Detection of Colorectal Cancer at American Society of Clinical Oncology's 2011 Gastrointestinal Cancers Symposium



1/19/2011 10:39:33 AM

(BUSINESS WIRE)--Neogenix Oncology announced today that it will present data on the development of a new stool biomarker ELISA that could lead to earlier detection of colorectal cancer. Data will be presented at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES